China SXT Pharmaceuticals

Quarterly Financials

Values in thousands 2025-06-30 2024-12-31
Revenue
$455
$455
Gross Profit
116
116
EBITDA
-1,014
-1,014
EBIT
-1,021
-1,021
Net Income
-1,250
-1,250
Net Change In Cash
455
455
Free Cash Flow
-495
-495
Cash
18,099
18,099
Basic Shares
2,442
2,442

Annual Financials

Values in thousands 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Revenue
$1,740
$1,928
$1,971
$2,602
Gross Profit
367
553
426
1,251
EBITDA
-2,573
-2,351
-5,207
-5,051
EBIT
-2,655
-2,554
-5,457
-5,371
Net Income
-3,303
-3,098
-5,934
-5,736
Net Change In Cash
1,740
1,928
1,971
2,602
Free Cash Flow
-2,347
-1,935
-151
205
Cash
18,099
12,070
17,368
15,524
Basic Shares
403
867
266
41

Earnings Calls

Quarter EPS
2025-06-30
-$1.02
2024-12-31
-$1.99
2022-06-30
-$2.03
2021-12-31
-$0.20